Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase (vol 8, pg 762, 2020)

被引：1
|
作者：
Pivonello, R.
Fleseriu, M.
Newell-Price, J.
机构：
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 09期
关键词：
D O I：
10.1016/S2213-8587(20)30275-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e4 / e4
页数：1
相关论文
共 50 条
  • [41] Radiotherapy for Ledderhose disease: Results of the LedRad-study, a prospective multicentre randomised double-blind phase 3 trial
    de Haan, Anneke
    van Nes, Johanna G. H.
    Kolff, M. Willemijn
    van der Toorn, Peter-Paul
    Westenberg, A. Helen
    van der Vegt, Annelies E.
    Groen, Henk
    Overbosch, Jelle
    van der Laan, Hans Paul
    Werker, Paul M. N.
    Langendijk, Johannes A.
    Steenbakkers, Roel J. H. M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 185
  • [42] Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
    Ramanan, Athimalaipet, V
    Quartier, Pierre
    Okamoto, Nami
    Foeldvari, Ivan
    Spindler, Alberto
    Fingerhutova, Sarka
    Anton, Jordi
    Wang, Zhongkai
    Meszaros, Gabriella
    Araujo, Joana
    Liao, Ran
    Keller, Stuart
    LANCET, 2023, 402 (10401): : 555 - 570
  • [43] A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever
    Koga, T.
    Sato, S.
    Hagimori, N.
    Yamamoto, H.
    Ishimura, M.
    Yasumi, T.
    Kirino, Y.
    Ikeda, K.
    Yachie, A.
    Migita, K.
    Kishida, D.
    Atsumi, T.
    Kawakami, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (08) : 1535 - 1542
  • [44] Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study
    Dauvilliers, Yves
    Arnulf, Isabelle
    Foldvary-Schaefer, Nancy
    Morse, Anne Marie
    Sonka, Karel
    Thorpy, Michael J.
    Mignot, Emmanuel
    Chandler, Patricia
    Parvataneni, Rupa
    Black, Jed
    Sterkel, Amanda
    Chen, Dan
    Skobieranda, Franck
    Bogan, Richard K.
    LANCET NEUROLOGY, 2022, 21 (01): : 53 - 65
  • [45] EFFICACY AND SAFETY OF JZP-258 IN A PHASE 3 DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMISED-WITHDRAWAL STUDY IN ADULTS WITH NARCOLEPSY WITH CATAPLEXY
    Bogan, R.
    Thorpy, M.
    Dauvilliers, Y.
    Villegas, R. Del Rio
    Foldvary-Schaefer, N.
    Skowronski, R.
    Liu, K.
    Skobieranda, F.
    Sonka, K.
    SLEEP MEDICINE, 2019, 64 : S43 - S43
  • [46] A phase III double blind, randomised, placebo controlled study of the efficacy, safety and tolerability of idebenone in the treatment of Friedreich's ataxia patients
    Giunti, P.
    Gray, J.
    Wood, N. W.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (09): : 1026 - 1026
  • [47] BARICITINIB IN JUVENILE IDIOPATHIC ARTHRITIS: A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, WITHDRAWAL, EFFICACY AND SAFETY STUDY
    Ramanan, A.
    Quartier, P.
    Okamoto, N.
    Meszaros, G.
    Araujo, J.
    Wang, Z.
    Liao, R.
    Crowe, B.
    Zhang, X.
    Decker, R.
    Keller, S.
    Brunner, H.
    Ruperto, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 207 - 208
  • [48] Baricitinib in Juvenile Idiopathic Arthritis: A Phase 3, Double-Blind, Placebo-Controlled, Withdrawal, Efficacy and Safety Study
    Ramanan, Athimalaipet
    Maire, Pierre Quartier Dit
    Okamoto, Nami
    Meszaros, Gabriella
    Araujo, Joana
    Wang, Zhongkai
    Liao, Ran
    Crowe, Brenda
    Zhang, Xin
    Decker, Rodney
    Keller, Stuart
    Brunner, Hermine
    Ruperto, Nicola
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4385 - 4387
  • [49] Efficacy and safety of oral ibrexafungerp in Chinese patients with vulvovaginal candidiasis: a phase III, randomized, double-blind study
    Wang, Xiaoqian
    Wang, Wenying
    Li, Jingjing
    An, Ruifang
    Chen, Lihong
    Lin, Jiajing
    Xu, Dabao
    Qiu, Jin
    Song, Weihua
    Patiman, Mijiti
    Ruan, Hongjie
    Wang, Gang
    Xue, Fengxia
    Wang, Xu
    Luo, Xiaowan
    Ruan, Qi
    Shi, Ling
    Zhang, Chun
    Hu, Lina
    Wang, Shijin
    Shi, Hong
    Wang, Xiaoli
    Zhang, Songling
    Li, Yingxiong
    Lu, Jing
    Wang, Baojin
    Xu, Hongyan
    Ye, Hong
    Zhang, Bei
    Zhang, Chunlian
    Qian, Sumin
    Wu, Qiong
    Jia, Wen
    Li, Chuan
    Liao, Qinping
    INFECTION, 2024, 52 (05) : 1787 - 1797
  • [50] Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
    Riva, Nilo
    Mora, Gabriele
    Soraru, Gianni
    Lunetta, Christian
    Ferraro, Ottavia E.
    Falzone, Yuri
    Leocani, Letizia
    Fazio, Raffaella
    Comola, Mauro
    Comi, Giancarlo
    Formaglio, Fabio
    Rossi, Paolo
    Clerici, Marta
    Falzone, Yuri Matteo
    Pozzi, Laura
    Martinelli, Daniele
    Cerri, Federica
    Diego, Lopez Ignazio
    Martinelli-Boneschi, Filippo
    Quattrini, Angelo
    Pieri, Elisabetta
    Marinou, Kalliopi
    Querin, Giorgia
    Sansone, Valeria
    Maestri, Eleonora
    Calvo, Andrea
    Chio, Adriano
    LANCET NEUROLOGY, 2019, 18 (02): : 155 - 164
12345